健之佳医药连锁集团股份有限公司 关于实际控制人的一致行动人权益变动触及1%刻度的提示性公告

Core Viewpoint - Yunnan Xiangqun Investment Co., Ltd., controlled by Mr. Lan Bo, plans to increase its stake in Jianzhijia Pharmaceutical Chain Group Co., Ltd. by investing 50 million yuan starting from January 1, 2026, through the Shanghai Stock Exchange [1] Group 1: Shareholding Increase Plan - Yunnan Xiangqun intends to increase its holdings of the company's A-shares through centralized bidding on the Shanghai Stock Exchange, with a total investment of 50 million yuan sourced from self-owned funds and a special loan for stock purchases [1] - The specific details of the increase plan will be disclosed in an announcement on January 1, 2026 [1] Group 2: Recent Shareholding Changes - From February 4 to February 24, 2026, Yunnan Xiangqun increased its holdings by 1,362,313 shares, accounting for 0.88% of the company's total share capital [2] - As of the announcement date, Yunnan Xiangqun holds 15,180,612 shares, representing 9.82% of the total share capital [2] Group 3: Compliance and Regulations - The shareholding increase complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Management Measures for the Acquisition of Listed Companies [2] - The total increase in shares by Yunnan Xiangqun and its concerted actions in the past 12 months does not exceed 2% of the company's total share capital, exempting them from the obligation to issue a public offer [2] - The increase will not affect the company's listing status or lead to changes in the actual controller or major shareholder [2][3]